Year |
Citation |
Score |
2023 |
Reas ET, Shadrin A, Frei O, Motazedi E, McEvoy L, Bahrami S, van der Meer D, Makowski C, Loughnan R, Wang X, Broce I, Banks SJ, Fominykh V, Cheng W, Holland D, ... ... Brewer JB, et al. Improved multimodal prediction of progression from MCI to Alzheimer's disease combining genetics with quantitative brain MRI and cognitive measures. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37132098 DOI: 10.1002/alz.13112 |
0.801 |
|
2022 |
Tsiknia AA, Sundermann EE, Reas ET, Edland SD, Brewer JB, Galasko D, Banks SJ. Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity. Alzheimer's Research & Therapy. 14: 160. PMID 36324151 DOI: 10.1186/s13195-022-01106-4 |
0.688 |
|
2022 |
Tsiknia AA, Edland SD, Sundermann EE, Reas ET, Brewer JB, Galasko D, Banks SJ. Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression. Molecular Psychiatry. PMID 35768637 DOI: 10.1038/s41380-022-01675-8 |
0.698 |
|
2022 |
Tsiknia AA, Reas E, Bangen KJ, Sundermann EE, McEvoy L, Brewer JB, Edland SD, Banks SJ. Sex and ɛ4 modify the effect of cardiovascular risk on tau in cognitively normal older adults. Brain Communications. 4: fcac035. PMID 35233525 DOI: 10.1093/braincomms/fcac035 |
0.754 |
|
2021 |
Banks SJ, Andrews MJ, Digma L, Madsen J, Reas ET, Caldwell JZK, McEvoy LK, Fan CC, Dale AM, Brewer JB. Sex differences in Alzheimer's disease: do differences in tau explain the verbal memory gap? Neurobiology of Aging. 107: 70-77. PMID 34399127 DOI: 10.1016/j.neurobiolaging.2021.05.013 |
0.778 |
|
2020 |
Spencer BE, Jennings RG, Fan CC, Brewer JB. Assessment of genetic risk for improved clinical-neuropathological correlations. Acta Neuropathologica Communications. 8: 160. PMID 32912321 DOI: 10.1186/S40478-020-01033-1 |
0.38 |
|
2020 |
Weigand AJ, Bondi MW, Thomas KR, Campbell NL, Galasko DR, Salmon DP, Sewell D, Brewer JB, Feldman HH, Delano-Wood L. Association of anticholinergic medication and AD biomarkers with incidence of MCI among cognitively normal older adults. Neurology. PMID 32878992 DOI: 10.1212/Wnl.0000000000010643 |
0.37 |
|
2020 |
Peavy GM, Jenkins CW, Little EA, Gigliotti C, Calcetas A, Edland SD, Brewer JB, Galasko D, Salmon DP. Community memory screening as a strategy for recruiting older adults into Alzheimer's disease research. Alzheimer's Research & Therapy. 12: 78. PMID 32605603 DOI: 10.1186/s13195-020-00643-0 |
0.412 |
|
2020 |
Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K, Gessert D, Aisen PS. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial. Jama Neurology. PMID 32568367 DOI: 10.1001/Jamaneurol.2020.1840 |
0.655 |
|
2019 |
Reas ET, Hagler DJ, Kuperman JM, Wierenga CE, Galasko D, White NS, Dale AM, Banks SJ, McEvoy LK, Brewer JB. Associations Between Microstructure, Amyloid, and Cognition in Amnestic Mild Cognitive Impairment and Dementia. Journal of Alzheimer's Disease : Jad. PMID 31796676 DOI: 10.3233/Jad-190871 |
0.777 |
|
2019 |
Nott A, Holtman IR, Coufal NG, Schlachetzki JCM, Yu M, Hu R, Han CZ, Pena M, Xiao J, Wu Y, Keulen Z, Pasillas MP, O'Connor C, Nickl CK, Schafer ST, ... ... Brewer JB, et al. Brain cell type-specific enhancer-promoter interactome maps and disease risk association. Science (New York, N.Y.). PMID 31727856 DOI: 10.1126/Science.Aay0793 |
0.357 |
|
2019 |
Weber DM, Tran D, Goldman SM, Taylor SW, Ginns EI, Lagier RJ, Rissman RA, Brewer JB, Clarke NJ. High-Throughput Mass Spectrometry Assay for Quantifying β-Amyloid 40 and 42 in Cerebrospinal Fluid. Clinical Chemistry. PMID 31628138 DOI: 10.1373/clinchem.2018.300947 |
0.327 |
|
2019 |
Digma LA, Madsen JR, Reas ET, Dale AM, Brewer JB, Banks SJ. Tau and atrophy: domain-specific relationships with cognition. Alzheimer's Research & Therapy. 11: 65. PMID 31351484 DOI: 10.1186/S13195-019-0518-8 |
0.734 |
|
2019 |
van Dyck CH, Nygaard HB, Chen K, Donohue MC, Raman R, Rissman RA, Brewer JB, Koeppe RA, Chow TW, Rafii MS, Gessert D, Choi J, Turner RS, Kaye JA, Gale SA, et al. Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial. Jama Neurology. PMID 31329216 DOI: 10.1001/Jamaneurol.2019.2050 |
0.614 |
|
2019 |
Schneider LS, Thomas RG, Hendrix S, Rissman RA, Brewer JB, Salmon DP, Oltersdorf T, Okuda T, Feldman HH. Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial. Jama Neurology. PMID 31282954 DOI: 10.1001/Jamaneurol.2019.1868 |
0.403 |
|
2019 |
Smirnov DS, Stasenko A, Salmon DP, Galasko D, Brewer JB, Gollan TH. Distinct structural correlates of the dominant and nondominant languages in bilinguals with Alzheimer's disease (AD). Neuropsychologia. 132: 107131. PMID 31271821 DOI: 10.1016/J.Neuropsychologia.2019.107131 |
0.372 |
|
2019 |
Spencer BE, Jennings RG, Brewer JB. Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer's Disease Neuroimaging Initiative. Journal of Alzheimer's Disease : Jad. PMID 30958366 DOI: 10.3233/Jad-181243 |
0.377 |
|
2019 |
Craft S, Raman R, Chow TW, Rafii MS, Rissman RA, Brewer JB, Donohue MC, Sun C, Harless K, Gessert D, Aisen PS. DT-02-03: OPEN LABEL EXTENSION RESULTS FROM A PHASE II/III TRIAL OF INTRANASAL INSULIN Alzheimer's & Dementia. 15: P1489-P1489. DOI: 10.1016/J.Jalz.2019.08.012 |
0.548 |
|
2019 |
Spencer BE, Digma LA, Murphy EA, Jennings RG, Fan CC, Desikan RS, Dale AM, Brewer JB. P1-436: UTILITY OF A GENETIC RISK ASSESSMENT FOR IMPROVED CLINICO-PATHOLOGIC CORRELATIONS Alzheimer's & Dementia. 15: P432-P433. DOI: 10.1016/J.Jalz.2019.06.1041 |
0.442 |
|
2019 |
Reas ET, Hagler DJ, White N, Kuperman J, Bartsch H, Wierenga C, Galasko DR, Dale AM, Banks SJ, Mcevoy L, Brewer JB. P1-414: ASSOCIATION OF BRAIN MICROSTRUCTURE AND AMYLOID-β WITH COGNITIVE DECLINE IN EARLY ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P421-P421. DOI: 10.1016/J.Jalz.2019.06.1019 |
0.773 |
|
2019 |
Banks SJ, Digma LA, Marsden J, Reas ET, Caldwell JZ, Mcevoy L, Fan CC, Dale AM, Brewer JB. P1-397: SEX AND COGNITION: RELATIONSHIPS WITH TAU AND APOLIPOPROTEIN E IN PRECLINICAL AND PRODROMAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P409-P409. DOI: 10.1016/J.Jalz.2019.06.1002 |
0.767 |
|
2018 |
Smirnov DS, Galasko D, Hansen LA, Edland SD, Brewer JB, Salmon DP. Trajectories of cognitive decline differ in hippocampal sclerosis and Alzheimer's disease. Neurobiology of Aging. 75: 169-177. PMID 30579145 DOI: 10.1016/J.Neurobiolaging.2018.11.015 |
0.447 |
|
2018 |
Broce IJ, Tan CH, Fan CC, Jansen I, Savage JE, Witoelar A, Wen N, Hess CP, Dillon WP, Glastonbury CM, Glymour M, Yokoyama JS, Elahi FM, Rabinovici GD, Miller BL, ... ... Brewer JB, et al. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease. Acta Neuropathologica. PMID 30413934 DOI: 10.1007/S00401-018-1928-6 |
0.576 |
|
2018 |
Soria JA, Huisa BN, Edland SD, Litvan I, Peavy GM, Salmon DP, Hansen LA, Galasko DR, Brewer JB, González HM, Rissman RA. Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers. Journal of Alzheimer's Disease : Jad. PMID 30412501 DOI: 10.3233/Jad-180789 |
0.366 |
|
2018 |
Reas ET, Hagler DJ, White NS, Kuperman JM, Bartsch H, Wierenga CE, Galasko D, Brewer JB, Dale AM, McEvoy LK. Microstructural brain changes track cognitive decline in mild cognitive impairment. Neuroimage. Clinical. 20: 883-891. PMID 30290303 DOI: 10.1016/J.Nicl.2018.09.027 |
0.782 |
|
2018 |
Rafii MS, Tuszynski MH, Thomas RG, Barba D, Brewer JB, Rissman RA, Siffert J, Aisen PS. Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial. Jama Neurology. PMID 29582053 DOI: 10.1001/Jamaneurol.2018.0233 |
0.611 |
|
2017 |
Tan CH, Fan CC, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Dillon WP, Bonham LW, Yokoyama JS, Karch CM, Brewer JB, Rabinovici GD, Miller BL, Schellenberg GD, Kauppi K, et al. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathologica. PMID 29177679 DOI: 10.1007/S00401-017-1789-4 |
0.605 |
|
2017 |
Rafii MS, Lukic AS, Andrews RD, Brewer J, Rissman RA, Strother SC, Wernick MN, Pennington C, Mobley WC, Ness S, Matthews DC. PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI). Journal of Alzheimer's Disease : Jad. 60: 439-450. PMID 28946567 DOI: 10.3233/Jad-170390 |
0.65 |
|
2017 |
Reas ET, Hagler DJ, White NS, Kuperman JM, Bartsch H, Cross K, Loi RQ, Balachandra AR, Meloy MJ, Wierenga CE, Galasko D, Brewer JB, Dale AM, McEvoy LK. Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer's disease. Alzheimer's Research & Therapy. 9: 55. PMID 28764771 DOI: 10.1186/S13195-017-0281-7 |
0.786 |
|
2017 |
Xiao MF, Xu D, Craig MT, Pelkey KA, Chien CC, Shi Y, Zhang J, Resnick S, Pletnikova O, Salmon D, Brewer J, Edland S, Wegiel J, Tycko B, Savonenko A, et al. NPTX2 and cognitive dysfunction in Alzheimer's Disease. Elife. 6. PMID 28440221 DOI: 10.7554/Elife.23798 |
0.4 |
|
2017 |
Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, Szabo P, Gelmont DM, Fritsch S, Aisen PS. A phase 3 trial of IV immunoglobulin for Alzheimer disease. Neurology. PMID 28381506 DOI: 10.1212/Wnl.0000000000003904 |
0.65 |
|
2017 |
Seibert TM, Karunamuni R, Kaifi S, Burkeen J, Connor M, Krishnan AP, White NS, Farid N, Bartsch H, Murzin V, Nguyen TT, Moiseenko V, Brewer JB, McDonald CR, Dale AM, et al. Cerebral Cortex Regions Selectively Vulnerable to Radiation Dose-Dependent Atrophy. International Journal of Radiation Oncology, Biology, Physics. 97: 910-918. PMID 28333012 DOI: 10.1016/J.Ijrobp.2017.01.005 |
0.741 |
|
2017 |
Desikan RS, Fan CC, Wang Y, Schork AJ, Cabral HJ, Cupples LA, Thompson WK, Besser L, Kukull WA, Holland D, Chen CH, Brewer JB, Karow DS, Kauppi K, Witoelar A, et al. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score. Plos Medicine. 14: e1002258. PMID 28323831 DOI: 10.1371/Journal.Pmed.1002258 |
0.571 |
|
2017 |
Karunamuni RA, Seibert TM, White NS, McEvoy L, Farid N, Brewer J, Dale AM, McDonald CR, Hattangadi-Gluth JA. Abnormalities in hippocampal volume of glioma patients prior to radiotherapy. Acta Oncologica (Stockholm, Sweden). 1-4. PMID 28156177 DOI: 10.1080/0284186X.2017.1280847 |
0.765 |
|
2017 |
Gimbel SI, Brewer JB, Maril A. I know I've seen you before: Distinguishing recent-single-exposure-based familiarity from pre-existing familiarity. Brain Research. PMID 28073651 DOI: 10.1016/J.Brainres.2017.01.007 |
0.655 |
|
2017 |
Seibert TM, Karunamuni R, Bartsch H, Kaifi S, Krishnan AP, Dalia Y, Burkeen J, Murzin V, Moiseenko V, Kuperman J, White NS, Brewer JB, Farid N, McDonald CR, Hattangadi-Gluth JA. Radiation Dose-Dependent Hippocampal Atrophy Detected With Longitudinal Volumetric Magnetic Resonance Imaging. International Journal of Radiation Oncology, Biology, Physics. 97: 263-269. PMID 28068234 DOI: 10.1016/J.Ijrobp.2016.10.035 |
0.735 |
|
2017 |
Xiao M, Xu D, Craig MT, Pelkey KA, Chien C, Shi Y, Zhang J, Resnick S, Pletnikova O, Salmon D, Brewer J, Edland S, Wegiel J, Tycko B, Savonenko A, et al. Author response: NPTX2 and cognitive dysfunction in Alzheimer’s Disease Elife. DOI: 10.7554/Elife.23798.027 |
0.347 |
|
2017 |
Galasko DR, Xiao M, Xu D, Zhang J, Craig MT, Pelkey K, Resnick SM, Troncoso JC, Reeves R, McBain C, Salmon DP, Brewer JB, Edland SD, Worley PF. NEURONAL PENTRAXIN 2 (NPTX2): A SYNAPTIC BIOMARKER OF COGNITIVE DYSFUNCTION IN ALZHEIMER’S DISEASE Alzheimer's & Dementia. 13: P1231-P1232. DOI: 10.1016/J.Jalz.2017.07.429 |
0.315 |
|
2017 |
Spencer BE, Digma LA, Brewer JB. [P3-420]: MEDIAL TEMPORAL ATROPHY AND ITS ASSOCIATION WITH AMYLOID STATUS AND NEUROPATHOLOGY Alzheimer's & Dementia. 13: P1126-P1126. DOI: 10.1016/j.jalz.2017.06.1637 |
0.333 |
|
2017 |
Weber DM, Goldman S, Clarke N, Lagier R, Rissman RA, Rowland C, Ginns EI, Brewer JB. [P1-239]: DEVELOPMENT OF A NOVEL MULTI-BIOMARKER ASSESSMENT SCORE FOR ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P336-P336. DOI: 10.1016/j.jalz.2017.06.059 |
0.339 |
|
2017 |
Seibert T, Karunamuni R, Tringale K, Nguyen T, Leyden K, Uttarwar V, Marshall D, Simpson D, Sanghvi P, Moiseenko V, Brewer J, Gorman M, Farid N, White N, Dale A, et al. Atrophy of Entorhinal Cortex After Radiation Therapy Associated With Memory Decline International Journal of Radiation Oncology*Biology*Physics. 99: S101. DOI: 10.1016/J.Ijrobp.2017.06.242 |
0.72 |
|
2016 |
Gelmont D, Thomas RG, Britt J, Dyck-Jones JA, Doralt J, Fritsch S, Brewer JB, Rissman RA, Aisen P. Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long-term, placebo-controlled study of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 2: 131-139. PMID 29067300 DOI: 10.1016/J.Trci.2016.06.003 |
0.322 |
|
2016 |
Matthews DC, Lukic AS, Andrews RD, Marendic B, Brewer J, Rissman RA, Mosconi L, Strother SC, Wernick MN, Mobley WC, Ness S, Schmidt ME, Rafii MS. Dissociation of Down syndrome and Alzheimer's disease effects with imaging. Alzheimer's & Dementia (New York, N. Y.). 2: 69-81. PMID 28642933 DOI: 10.1016/J.Trci.2016.02.004 |
0.658 |
|
2016 |
Ferrari R, Wang Y, Vandrovcova J, Guelfi S, Witeolar A, Karch CM, Schork AJ, Fan CC, Brewer JB, Momeni P, Schellenberg GS, Dillon WP, et al. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27899424 DOI: 10.1136/Jnnp-2016-314411 |
0.352 |
|
2016 |
Seibert TM, Karunamuni R, Kaifi S, Burkeen J, Krishnan A, McDonald C, White N, Farid N, Bartsch H, Nguyen T, Moiseenko V, Brewer J, Dale A, Hattangadi JA. Selective Vulnerability of Cerebral Cortex Regions to Radiation Dose-Dependent Atrophy. International Journal of Radiation Oncology, Biology, Physics. 96: S177. PMID 27675715 DOI: 10.1016/J.Ijrobp.2016.06.445 |
0.681 |
|
2016 |
Yokoyama JS, Wang Y, Schork AJ, Thompson WK, Karch CM, Cruchaga C, McEvoy LK, Witoelar A, Chen CH, Holland D, Brewer JB, Franke A, Dillon WP, Wilson DM, Mukherjee P, et al. Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease. Jama Neurology. PMID 27088644 DOI: 10.1001/Jamaneurol.2016.0150 |
0.596 |
|
2016 |
Karunamuni R, Bartsch H, White NS, Moiseenko V, Carmona R, Marshall DC, Seibert TM, McDonald CR, Farid N, Krishnan A, Kuperman J, Mell L, Brewer JB, Dale AM, Hattangadi-Gluth JA. Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma. International Journal of Radiation Oncology, Biology, Physics. 94: 297-304. PMID 26853338 DOI: 10.1016/J.Ijrobp.2015.10.026 |
0.725 |
|
2016 |
Karunamuni RA, Moore KL, Seibert TM, Li N, White NS, Bartsch H, Carmona R, Marshall D, McDonald CR, Farid N, Krishnan A, Kuperman J, Mell LK, Brewer J, Dale AM, et al. Radiation sparing of cerebral cortex in brain tumor patients using quantitative neuroimaging. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26806266 DOI: 10.1016/J.Radonc.2016.01.003 |
0.714 |
|
2016 |
Matthews DC, Lukic AS, Andrews RD, Marendic B, Brewer J, Rissman RA, Mosconi L, Strother SC, Wernick MN, Mobley WC, Ness S, Schmidt ME, Rafii MS. Dissociation of Down syndrome and Alzheimer's disease effects with imaging Alzheimer's and Dementia: Translational Research and Clinical Interventions. 2: 69-81. DOI: 10.1016/j.trci.2016.02.004 |
0.625 |
|
2015 |
Rafii MS, Wishnek H, Brewer JB, Donohue MC, Ness S, Mobley WC, Aisen PS, Rissman RA. The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome. Frontiers in Behavioral Neuroscience. 9: 239. PMID 26441570 DOI: 10.3389/Fnbeh.2015.00239 |
0.661 |
|
2015 |
Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. PMID 26362286 DOI: 10.1212/Wnl.0000000000002035 |
0.34 |
|
2015 |
Jack CR, Barnes J, Bernstein MA, Borowski BJ, Brewer J, Clegg S, Dale AM, Carmichael O, Ching C, DeCarli C, Desikan RS, Fennema-Notestine C, Fjell AM, Fletcher E, Fox NC, et al. Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 740-56. PMID 26194310 DOI: 10.1016/J.Jalz.2015.05.002 |
0.594 |
|
2015 |
Desikan RS, Schork AJ, Wang Y, Thompson WK, Dehghan A, Ridker PM, Chasman DI, McEvoy LK, Holland D, Chen CH, Karow DS, Brewer JB, Hess CP, Williams J, Sims R, et al. Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease. Circulation. 131: 2061-9. PMID 25862742 DOI: 10.1161/Circulationaha.115.015489 |
0.58 |
|
2015 |
Desikan RS, Schork AJ, Wang Y, Witoelar A, Sharma M, McEvoy LK, Holland D, Brewer JB, Chen CH, Thompson WK, Harold D, Williams J, Owen MJ, O'Donovan MC, Pericak-Vance MA, et al. Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus. Molecular Psychiatry. PMID 25687773 DOI: 10.1038/Mp.2015.6 |
0.535 |
|
2015 |
Reas ET, Brewer JB. Mean signal and response time influences on multivoxel signals of contextual retrieval in the medial temporal lobe. Brain and Behavior. 5: e00302. PMID 25646149 DOI: 10.1002/Brb3.302 |
0.727 |
|
2015 |
Karunamuni R, Bartsch H, White N, Moiseenko V, Carmona R, Marshall D, Seibert T, McDonald C, Farid N, Krishnan A, Brewer J, Dale A, Hattangadi J. Dose-Dependent Cortical Thinning After Partial-Brain Radiation in Glioblastoma International Journal of Radiation Oncology*Biology*Physics. 93: S175. DOI: 10.1016/J.Ijrobp.2015.07.421 |
0.702 |
|
2015 |
Marshall D, Karunamuni R, White N, McDonald C, Moiseenko V, Bartsch H, Seibert T, Farid N, Brewer J, Krishnan A, Dale A, Hattangadi J. Quantitative Analysis of Radiation Induced Microstructural Injury to White Matter and Hippocampus in Brain Tumor Patients International Journal of Radiation Oncology*Biology*Physics. 93: S97-S98. DOI: 10.1016/J.Ijrobp.2015.07.233 |
0.693 |
|
2014 |
Brezova V, Moen KG, Skandsen T, Vik A, Brewer JB, Salvesen O, Håberg AK. Prospective longitudinal MRI study of brain volumes and diffusion changes during the first year after moderate to severe traumatic brain injury. Neuroimage. Clinical. 5: 128-40. PMID 25068105 DOI: 10.1016/J.Nicl.2014.03.012 |
0.309 |
|
2014 |
Hill DL, Schwarz AJ, Isaac M, Pani L, Vamvakas S, Hemmings R, Carrillo MC, Yu P, Sun J, Beckett L, Boccardi M, Brewer J, Brumfield M, Cantillon M, Cole PE, et al. Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 421-9.e3. PMID 24985687 DOI: 10.1016/J.Jalz.2013.07.003 |
0.329 |
|
2014 |
Gimbel SI, Brewer JB. Elaboration versus suppression of cued memories: influence of memory recall instruction and success on parietal lobe, default network, and hippocampal activity. Plos One. 9: e89037. PMID 24586492 DOI: 10.1371/Journal.Pone.0089037 |
0.674 |
|
2014 |
Desikan RS, Thompson WK, Holland D, Hess CP, Brewer JB, Zetterberg H, Blennow K, Andreassen OA, McEvoy LK, Hyman BT, Dale AM. The role of clusterin in amyloid-β-associated neurodegeneration. Jama Neurology. 71: 180-7. PMID 24378367 DOI: 10.1001/Jamaneurol.2013.4560 |
0.631 |
|
2014 |
Yu P, Sun J, Wolz R, Stephenson D, Brewer J, Fox NC, Cole PE, Jack CR, Hill DL, Schwarz AJ. Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size. Neurobiology of Aging. 35: 808-18. PMID 24211008 DOI: 10.1016/J.Neurobiolaging.2013.09.039 |
0.355 |
|
2014 |
Rafii MS, Taylor CS, Kim HT, Desikan RS, Fleisher AS, Katibian D, Brewer JB, Dale AM, Aisen PS. Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer's disease. American Journal of Alzheimer's Disease and Other Dementias. 29: 159-65. PMID 24164929 DOI: 10.1177/1533317513507373 |
0.667 |
|
2013 |
Desikan RS, Thompson WK, Holland D, Hess CP, Brewer JB, Zetterberg H, Blennow K, Andreassen OA, McEvoy LK, Hyman BT, Dale AM. Heart fatty acid binding protein and Aβ-associated Alzheimer's neurodegeneration. Molecular Neurodegeneration. 8: 39. PMID 24088526 DOI: 10.1186/1750-1326-8-39 |
0.592 |
|
2013 |
Reas ET, Brewer JB. Imbalance of incidental encoding across tasks: an explanation for non-memory-related hippocampal activations? Journal of Experimental Psychology. General. 142: 1171-9. PMID 23773160 DOI: 10.1037/A0033461 |
0.736 |
|
2013 |
Desikan RS, Rafii MS, Brewer JB, Hess CP. An expanded role for neuroimaging in the evaluation of memory impairment. Ajnr. American Journal of Neuroradiology. 34: 2075-82. PMID 23764728 DOI: 10.3174/ajnr.A3644 |
0.696 |
|
2013 |
Reas ET, Brewer JB. Effortful retrieval reduces hippocampal activity and impairs incidental encoding. Hippocampus. 23: 367-79. PMID 23378272 DOI: 10.1002/Hipo.22096 |
0.733 |
|
2013 |
Reas ET, Gimbel SI, Hales JB, Brewer JB. Erratum: search-related suppression of hippocampus and default network activity during associative memory retrieval. Frontiers in Human Neuroscience. 7: 2. PMID 23355818 DOI: 10.3389/Fnhum.2013.00002 |
0.805 |
|
2013 |
Hales JB, Brewer JB. Parietal and frontal contributions to episodic encoding of location. Behavioural Brain Research. 243: 16-20. PMID 23295390 DOI: 10.1016/J.Bbr.2012.12.048 |
0.726 |
|
2013 |
Reas ET, Brewer JB. Retrieval search and strength evoke dissociable brain activity during episodic memory recall. Journal of Cognitive Neuroscience. 25: 219-33. PMID 23190328 DOI: 10.1162/Jocn_A_00335 |
0.741 |
|
2013 |
Desikan RS, McEvoy LK, Holland D, Thompson WK, Brewer JB, Aisen PS, Andreassen OA, Hyman BT, Sperling RA, Dale AM. Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease. Ajnr. American Journal of Neuroradiology. 34: 505-10. PMID 22976236 DOI: 10.3174/Ajnr.A3267 |
0.614 |
|
2012 |
McEvoy LK, Brewer JB. Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough. Imaging in Medicine. 4: 343-357. PMID 23420460 DOI: 10.2217/Iim.12.27 |
0.618 |
|
2012 |
Desikan RS, McEvoy LK, Thompson WK, Holland D, Brewer JB, Aisen PS, Sperling RA, Dale AM. Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau. Archives of Neurology. 69: 709-13. PMID 22529247 DOI: 10.1001/Archneurol.2011.3354 |
0.608 |
|
2012 |
Hales JB, Brewer JB. The path to memory is guided by strategy: distinct networks are engaged in associative encoding under visual and verbal strategy and influence memory performance in healthy and impaired individuals. Journal of Cognitive Neuroscience. 24: 1398-410. PMID 22390467 DOI: 10.1162/Jocn_A_00220 |
0.764 |
|
2012 |
Seibert TM, Murphy EA, Kaestner EJ, Brewer JB. Interregional correlations in Parkinson disease and Parkinson-related dementia with resting functional MR imaging. Radiology. 263: 226-34. PMID 22371611 DOI: 10.1148/Radiol.12111280 |
0.772 |
|
2012 |
Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, ... ... Brewer J, et al. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proceedings of the National Academy of Sciences of the United States of America. 109: 3985-90. PMID 22343285 DOI: 10.1073/Pnas.1105829109 |
0.528 |
|
2012 |
Seibert TM, Majid DS, Aron AR, Corey-Bloom J, Brewer JB. Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease. Neuroimage. 59: 2452-63. PMID 21945695 DOI: 10.1016/J.Neuroimage.2011.08.105 |
0.726 |
|
2012 |
Murphy EA, Roddey JC, McEvoy LK, Holland D, Hagler DJ, Dale AM, Brewer JB. CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner. Brain Imaging and Behavior. 6: 16-26. PMID 21892657 DOI: 10.1007/S11682-011-9137-0 |
0.694 |
|
2012 |
Desikan R, McEvoy L, Schork A, Thompson W, Brewer J, Van De Bunt M, Morris A, McCarthy M, Owen M, O'Donovan M, Williams J, Hyman B, Andreassen O, Dale A. O1-09-05: On genetic pleiotropy between Alzheimer's disease and cardiovascular risk factors Alzheimer's & Dementia. 8: P101-P102. DOI: 10.1016/J.Jalz.2012.05.255 |
0.542 |
|
2011 |
Reas ET, Gimbel SI, Hales JB, Brewer JB. Search-Related Suppression of Hippocampus and Default Network Activity during Associative Memory Retrieval. Frontiers in Human Neuroscience. 5: 112. PMID 22046159 DOI: 10.3389/fnhum.2011.00112 |
0.807 |
|
2011 |
Desikan RS, McEvoy LK, Thompson WK, Holland D, Roddey JC, Blennow K, Aisen PS, Brewer JB, Hyman BT, Dale AM. Amyloid-β associated volume loss occurs only in the presence of phospho-tau. Annals of Neurology. 70: 657-61. PMID 22002658 DOI: 10.1002/Ana.22509 |
0.631 |
|
2011 |
Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK. Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology. 77: 1619-28. PMID 21998317 DOI: 10.1212/Wnl.0B013E3182343314 |
0.583 |
|
2011 |
Seibert TM, Brewer JB. Default network correlations analyzed on native surfaces. Journal of Neuroscience Methods. 198: 301-11. PMID 21514321 DOI: 10.1016/J.Jneumeth.2011.04.010 |
0.746 |
|
2011 |
McEvoy LK, Holland D, Hagler DJ, Fennema-Notestine C, Brewer JB, Dale AM. Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis. Radiology. 259: 834-43. PMID 21471273 DOI: 10.1148/Radiol.11101975 |
0.583 |
|
2011 |
Gimbel SI, Brewer JB. Reaction time, memory strength, and fMRI activity during memory retrieval: Hippocampus and default network are differentially responsive during recollection and familiarity judgments. Cognitive Neuroscience. 2: 19-23. PMID 21278912 DOI: 10.1080/17588928.2010.513770 |
0.665 |
|
2011 |
Hales JB, Brewer JB. The timing of associative memory formation: frontal lobe and anterior medial temporal lobe activity at associative binding predicts memory. Journal of Neurophysiology. 105: 1454-63. PMID 21248058 DOI: 10.1152/Jn.00902.2010 |
0.777 |
|
2011 |
Seibert TM, Gimbel SI, Hagler DJ, Brewer JB. Parietal activity in episodic retrieval measured by fMRI and MEG. Neuroimage. 55: 788-93. PMID 21134473 DOI: 10.1016/J.Neuroimage.2010.11.078 |
0.793 |
|
2011 |
Seibert TM, Hagler DJ, Brewer JB. Early parietal response in episodic retrieval revealed with MEG. Human Brain Mapping. 32: 171-81. PMID 20623759 DOI: 10.1016/S1053-8119(09)70494-X |
0.744 |
|
2011 |
McEvoy L, Heister D, Blennow K, Brewer J, Dale A. IC-02-02: Predicting progression to Alzheimer's Disease in MCI using combined structural imaging and CSF biomarkers Alzheimer's & Dementia. 7: S3-S4. DOI: 10.1016/J.Jalz.2011.05.009 |
0.578 |
|
2010 |
Rafii MS, Brewer JB. Functional brain imaging in the clinical assessment of consciousness. Plos Biology. 8: e1000548. PMID 21151340 DOI: 10.1371/journal.pbio.1000548 |
0.612 |
|
2010 |
McEvoy LK, Brewer JB. Quantitative structural MRI for early detection of Alzheimer's disease. Expert Review of Neurotherapeutics. 10: 1675-88. PMID 20977326 DOI: 10.1586/Ern.10.162 |
0.619 |
|
2010 |
Karow DS, McEvoy LK, Fennema-Notestine C, Hagler DJ, Jennings RG, Brewer JB, Hoh CK, Dale AM. Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology. 256: 932-42. PMID 20720076 DOI: 10.1148/Radiol.10091402 |
0.599 |
|
2010 |
McEvoy LK, Edland SD, Holland D, Hagler DJ, Roddey JC, Fennema-Notestine C, Salmon DP, Koyama AK, Aisen PS, Brewer JB, Dale AM. Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease. Alzheimer Disease and Associated Disorders. 24: 269-77. PMID 20683184 DOI: 10.1097/Wad.0B013E3181D1B814 |
0.61 |
|
2010 |
Hales JB, Brewer JB. Activity in the hippocampus and neocortical working memory regions predicts successful associative memory for temporally discontiguous events. Neuropsychologia. 48: 3351-9. PMID 20667491 DOI: 10.1016/J.Neuropsychologia.2010.07.025 |
0.773 |
|
2010 |
Murphy EA, Holland D, Donohue M, McEvoy LK, Hagler DJ, Dale AM, Brewer JB. Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls. Neuroimage. 53: 1310-7. PMID 20633660 DOI: 10.1016/J.Neuroimage.2010.07.016 |
0.709 |
|
2010 |
Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM. CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2088-101. PMID 20147537 DOI: 10.1523/Jneurosci.3785-09.2010 |
0.631 |
|
2010 |
Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, Hagler DJ, Jennings RG, Karow D, Dale AM. Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. Ajnr. American Journal of Neuroradiology. 31: 347-54. PMID 20075088 DOI: 10.3174/Ajnr.A1809 |
0.616 |
|
2010 |
Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Blennow K, Brewer JB, Dale AM. Brain atrophy in healthy aging is related to CSF levels of Aβ1-42. Cerebral Cortex (New York, N.Y. : 1991). 20: 2069-79. PMID 20051356 DOI: 10.1093/Cercor/Bhp279 |
0.596 |
|
2010 |
Israel SL, Seibert TM, Black ML, Brewer JB. Going their separate ways: dissociation of hippocampal and dorsolateral prefrontal activation during episodic retrieval and post-retrieval processing. Journal of Cognitive Neuroscience. 22: 513-25. PMID 19301994 DOI: 10.1162/Jocn.2009.21198 |
0.788 |
|
2010 |
Walhovd KB, Fjell AM, Dale AM, McEvoy LK, Brewer J, Karow DS, Salmon DP, Fennema-Notestine C. Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiology of Aging. 31: 1107-21. PMID 18838195 DOI: 10.1016/J.Neurobiolaging.2008.08.013 |
0.619 |
|
2009 |
Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Fenema-Notestine C, Dale AM. Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 106: 20954-9. PMID 19996185 DOI: 10.1073/Pnas.0906053106 |
0.456 |
|
2009 |
Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM. One-year brain atrophy evident in healthy aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 15223-31. PMID 19955375 DOI: 10.1523/Jneurosci.3252-09.2009 |
0.618 |
|
2009 |
Fleisher AS, Donohue M, Chen K, Brewer JB, Aisen PS. Applications of neuroimaging to disease-modification trials in Alzheimer's disease. Behavioural Neurology. 21: 129-36. PMID 19847051 DOI: 10.3233/Ben-2009-0241 |
0.422 |
|
2009 |
Brewer JB. Fully-automated volumetric MRI with normative ranges: translation to clinical practice. Behavioural Neurology. 21: 21-8. PMID 19847042 DOI: 10.3233/BEN-2009-0226 |
0.41 |
|
2009 |
McDonald CR, McEvoy LK, Gharapetian L, Fennema-Notestine C, Hagler DJ, Holland D, Koyama A, Brewer JB, Dale AM. Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology. 73: 457-65. PMID 19667321 DOI: 10.1212/Wnl.0B013E3181B16431 |
0.629 |
|
2009 |
Kovacevic S, Rafii MS, Brewer JB. High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimer Disease and Associated Disorders. 23: 139-45. PMID 19474571 DOI: 10.1097/WAD.0b013e318192e745 |
0.666 |
|
2009 |
McEvoy LK, Fennema-Notestine C, Roddey JC, Hagler DJ, Holland D, Karow DS, Pung CJ, Brewer JB, Dale AM. Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology. 251: 195-205. PMID 19201945 DOI: 10.1148/Radiol.2511080924 |
0.618 |
|
2009 |
Brewer JB, Magda S, Airriess C, Smith ME. Fully-automated quantification of regional brain volumes for improved detection of focal atrophy in Alzheimer disease. Ajnr. American Journal of Neuroradiology. 30: 578-80. PMID 19112065 DOI: 10.3174/ajnr.A1402 |
0.419 |
|
2009 |
Hales JB, Israel SL, Swann NC, Brewer JB. Dissociation of frontal and medial temporal lobe activity in maintenance and binding of sequentially presented paired associates. Journal of Cognitive Neuroscience. 21: 1244-54. PMID 18752401 DOI: 10.1162/Jocn.2009.21096 |
0.794 |
|
2008 |
Edland SD, McEvoy LK, Holland D, Roddey JC, Fennema-Notestine C, Brewer JB, Dale AM. P1-188: Enrichment strategies for secondary prevention trials: The effect of restrictive inclusion criteria on statistical power and sample size Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.776 |
0.492 |
|
2008 |
McEvoy LK, Karow DS, Fennema-Notestine C, Hagler DJ, Roddey JC, Holland D, Jennings RG, Brewer JB, Dale AM. IC-P2-115: Regional metabolism in MCI predicts clinical decline and structural volume loss: Initial results from the Alzheimer's disease neuroimaging initiative Alzheimer's & Dementia. 4: T53-T53. DOI: 10.1016/J.Jalz.2008.05.2570 |
0.586 |
|
2008 |
McEvoy LK, Karow DS, Fennema-Notestine C, Hagler DJ, Roddey JC, Holland D, Jennings RG, Brewer JB, Dale AM. P2-051: Regional metabolism in mild cognitive impairment predicts clinical decline and structural volume loss: Initial results from the Alzheimer's disease neuroimaging initiative (ADNI) Alzheimer's & Dementia. 4: T381-T382. DOI: 10.1016/J.Jalz.2008.05.1124 |
0.616 |
|
2008 |
Edland SD, Holland D, Fennema-Notestine C, Hagler DJ, McEvoy LK, Brewer JB, Dale AM. IC-P2-092: The relative performance of different structural MRI measures as outcomes in secondary prevention trials: Statistical considerations of power and sample size Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.085 |
0.505 |
|
2008 |
Brewer JB, Holland DJ, Fennema-Notestine C, Dale AM. IC-P2-080: Brain structure change is associated with clinical decline of elderly controls: A longitudinal study using the ADNI dataset Alzheimer's & Dementia. 4: T40-T40. DOI: 10.1016/J.Jalz.2008.05.073 |
0.371 |
|
2007 |
Karow DS, Hagler DJ, Fennema-Notestine C, McEvoy LK, Wu EH, Brewer JB, Fleisher AS, Hoh CK, Dale AM. P-042: Preliminary cross-sectional analysis of pet data from the Alzheimer's disease neuroimaging initiative using morphometry birn procedures Alzheimer's & Dementia. 3: S110-S110. DOI: 10.1016/J.Jalz.2007.04.258 |
0.553 |
|
2007 |
Brewer JB, Gabrieli JDE, Preston AR, Vaidya CJ, Rosen AC. Memory Textbook of Clinical Neurology. 63-78. DOI: 10.1016/B978-141603618-0.10005-0 |
0.736 |
|
2006 |
Gold JJ, Smith CN, Bayley PJ, Shrager Y, Brewer JB, Stark CE, Hopkins RO, Squire LR. Item memory, source memory, and the medial temporal lobe: concordant findings from fMRI and memory-impaired patients. Proceedings of the National Academy of Sciences of the United States of America. 103: 9351-6. PMID 16751272 DOI: 10.1073/Pnas.0602716103 |
0.571 |
|
2006 |
Weigand AJ, Bondi MW, Thomas KR, Galasko DR, Salmon D, Sewell DD, Brewer JB, Feldman HH, Delano-Wood L. P2-590: ANTICHOLINERGIC MEDICATION USE INTERACTS WITH APOE-ɛ4 GENOTYPE TO INCREASE RISK FOR INCIDENT MCI OVER A 10-YEAR PERIOD AMONG COGNITIVELY HEALTHY OLDER ADULTS: AN ALZHEIMER'S DISEASE NEUROIMAGING STUDY Alzheimer's & Dementia. 14: P963-P964. DOI: 10.1016/J.Jalz.2018.06.1285 |
0.363 |
|
2006 |
Spencer BE, Jennings RG, Brewer JB. P1-005: BASELINE RISK OF DEMENTIA CONVERSION AMONG PATIENTS WITH MILD COGNITIVE IMPAIRMENT: EIGHT-YEAR RETROSPECTIVE Alzheimer's & Dementia. 14: P263-P264. DOI: 10.1016/J.Jalz.2018.06.006 |
0.349 |
|
2002 |
Brewer JB, Moghekar A. Imaging the medial temporal lobe: exploring new dimensions. Trends in Cognitive Sciences. 6: 217-223. PMID 11983585 DOI: 10.1016/S1364-6613(02)01881-8 |
0.388 |
|
2001 |
Golby AJ, Poldrack RA, Brewer JB, Spencer D, Desmond JE, Aron AP, Gabrieli JD. Material-specific lateralization in the medial temporal lobe and prefrontal cortex during memory encoding. Brain : a Journal of Neurology. 124: 1841-54. PMID 11522586 DOI: 10.1093/Brain/124.9.1841 |
0.677 |
|
2000 |
Canli T, Zhao Z, Brewer J, Gabrieli JD, Cahill L. Event-related activation in the human amygdala associates with later memory for individual emotional experience. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: RC99. PMID 11000199 DOI: 10.1523/Jneurosci.20-19-J0004.2000 |
0.575 |
|
1999 |
Fernández G, Brewer JB, Zhao Z, Glover GH, Gabrieli JD. Level of sustained entorhinal activity at study correlates with subsequent cued-recall performance: a functional magnetic resonance imaging study with high acquisition rate. Hippocampus. 9: 35-44. PMID 10088898 DOI: 10.1002/(Sici)1098-1063(1999)9:1<35::Aid-Hipo4>3.0.Co;2-Z |
0.59 |
|
1998 |
Gabrieli JD, Brewer JB, Poldrack RA. Images of medial temporal lobe functions in human learning and memory. Neurobiology of Learning and Memory. 70: 275-83. PMID 9753602 DOI: 10.1006/nlme.1998.3853 |
0.691 |
|
1998 |
Brewer JB, Zhao Z, Desmond JE, Glover GH, Gabrieli JD. Making memories: brain activity that predicts how well visual experience will be remembered. Science (New York, N.Y.). 281: 1185-7. PMID 9712581 DOI: 10.1126/Science.281.5380.1185 |
0.595 |
|
1997 |
Brewer JB, Gabrieli JD. Focusing in on the medial temporal lobe. Molecular Psychiatry. 2: 430-1, 427-8. PMID 9399679 DOI: 10.1038/Sj.Mp.4000299 |
0.502 |
|
1997 |
Gabrieli JD, Brewer JB, Desmond JE, Glover GH. Separate neural bases of two fundamental memory processes in the human medial temporal lobe. Science (New York, N.Y.). 276: 264-6. PMID 9092477 DOI: 10.1126/Science.276.5310.264 |
0.592 |
|
1997 |
Brewer JB. Distinct functional MRI activations in the medial temporal lobe during encoding and retrieval of memories Molecular Psychiatry. 2: 427-428. DOI: 10.1038/SJ.MP.4000301 |
0.409 |
|
Show low-probability matches. |